First in Human Study of EI-001 Monoclonal Antibody in Healthy Volunteers
Clinical trial NCT04994912 · COMPLETED
Trial details
- NCT number
- NCT04994912
- Sponsor
- Elixiron Immunotherapeutics (Hong Kong) Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-01
- Primary completion
- 2025-01-07
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.